[PDF] British Association for Sexual Health and HIV national guideline for the management of infection with Neisseria gonorrhoeae (2019)

Source:
British Association for Sexual Health and HIV - BASHH
Publisher:
British Association for Sexual Health and HIV
Publication date:
20 January 2019

Abstract

Changes since 2011 guideline • First line empirical treatment is now monotherapy with ceftriaxone 1g intramuscularly • If antimicrobial susceptibility test results from all sites of infection are available prior to treatment and the isolate is sensitive to ciprofloxacin, then this should be used for treatment in preference to ceftriaxone • Inclusion of testing recommendations in people following genital reconstructive surgery • Recommendations for extra-genital testing in those with suspected or confirmed antimicrobial resistance • Epidemiological treatment is recommended only for those presenting within 14 days of exposure. For those presenting after 14 days of exposure we recommend treatment based on the results of testing